Borisy Alexis — SEC Form 4 filings
SEC reporting owner CIK 1319446. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-23.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-05 to 2026-06-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Blueprint Medicines Corp (BPMC) | Director | 3 | — | — | 12 |
| Revolution Medicines, Inc. (RVMD) | Director | 4 | — | — | 8 |
| Tango Therapeutics, Inc. (TNGX) | Director | 2 | — | — | 4 |
| Parabilis Medicines, Inc. (PBLS) | Director | 2 | — | — | 3 |
| Relay Therapeutics, Inc. (RLAY) | Director | 3 | — | — | 3 |
Form 4 filings — Borisy Alexis
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-23 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Parabilis Medicines, Inc. (PBLS) | Conversion (C): 105,414 · Conversion (C): 162,221 (derivative) | EDGAR |
| 2026-06-11 | 4 | Parabilis Medicines, Inc. (PBLS) | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 32,947 (derivative) @ $0 | EDGAR |
| 2025-07-21 | 4 | Blueprint Medicines Corp (BPMC) | Disposition to issuer (D): 3,902 · Code (U): 74,160 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 4,875 (derivative) · Disposition to issuer (D): 4,500 (derivative) · Disposition to issuer (D): 4,500 (derivative) · +3 more | EDGAR |
| 2025-06-30 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 3,142 @ $0 · Grant/award (A): 11,574 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 3,902 @ $128.12 | EDGAR |
| 2025-06-09 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 136,681 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4/A | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 4,248 @ $0 · Grant/award (A): 15,955 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 4,800 @ $0 · Grant/award (A): 16,700 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Blueprint Medicines Corp (BPMC) | Grant/award (A): 2,242 @ $0 · Grant/award (A): 4,570 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 6,250 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 102,225 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1319446 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →